DE69616559D1 - Hilfsvirus für die herstellung von rekombinanten virusvektoren - Google Patents

Hilfsvirus für die herstellung von rekombinanten virusvektoren

Info

Publication number
DE69616559D1
DE69616559D1 DE69616559T DE69616559T DE69616559D1 DE 69616559 D1 DE69616559 D1 DE 69616559D1 DE 69616559 T DE69616559 T DE 69616559T DE 69616559 T DE69616559 T DE 69616559T DE 69616559 D1 DE69616559 D1 DE 69616559D1
Authority
DE
Germany
Prior art keywords
virus
production
auxiliary
vectors
recombinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69616559T
Other languages
English (en)
Other versions
DE69616559T2 (de
Inventor
Monika Lusky
Majid Mehtali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Publication of DE69616559D1 publication Critical patent/DE69616559D1/de
Application granted granted Critical
Publication of DE69616559T2 publication Critical patent/DE69616559T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C12N2710/10352—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DE69616559T 1995-07-31 1996-07-30 Hilfsvirus für die herstellung von rekombinanten virusvektoren Expired - Fee Related DE69616559T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509289A FR2737501B1 (fr) 1995-07-31 1995-07-31 Nouveaux virus auxiliaires pour la preparation de vecteurs viraux recombinants
PCT/FR1996/001200 WO1997005255A2 (fr) 1995-07-31 1996-07-30 Virus auxiliaires pour la preparation de vecteurs viraux recombinants

Publications (2)

Publication Number Publication Date
DE69616559D1 true DE69616559D1 (de) 2001-12-06
DE69616559T2 DE69616559T2 (de) 2002-06-27

Family

ID=9481555

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69616559T Expired - Fee Related DE69616559T2 (de) 1995-07-31 1996-07-30 Hilfsvirus für die herstellung von rekombinanten virusvektoren

Country Status (12)

Country Link
US (3) US6066478A (de)
EP (2) EP0842279B1 (de)
JP (1) JP3416143B2 (de)
AT (1) ATE207959T1 (de)
AU (1) AU715487B2 (de)
CA (1) CA2225551A1 (de)
DE (1) DE69616559T2 (de)
DK (1) DK0842279T3 (de)
ES (1) ES2164910T3 (de)
FR (1) FR2737501B1 (de)
PT (1) PT842279E (de)
WO (1) WO1997005255A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020146392A1 (en) * 1993-06-24 2002-10-10 Frank L. Graham Helper dependent adenovirus vectors based on site-specific recombinases
US7045347B2 (en) 1993-06-24 2006-05-16 Advec, Inc. Helper dependent adenovirus vectors based on integrase family site-specific recombinases
US20020136708A1 (en) 1993-06-24 2002-09-26 Graham Frank L. System for production of helper dependent adenovirus vectors based on use of endonucleases
JP4216350B2 (ja) * 1994-09-19 2009-01-28 大日本住友製薬株式会社 動物細胞感染用の組換えｄｎａウイルスベクター
AU2004201152B2 (en) * 1995-06-07 2007-03-08 Advec, Inc. Helper Dependent Adenovirus Vectors Based on Site-specific Recombinases
US6783980B2 (en) 1995-06-15 2004-08-31 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
SI0833934T2 (sl) 1995-06-15 2013-04-30 Crucell Holland B.V. Pakirni sistemi za humani rekombinantni adenovirus za uporabo v genski terapiji
US6265212B1 (en) 1995-06-15 2001-07-24 Introgene B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
WO1999041400A1 (en) * 1998-02-17 1999-08-19 Genzyme Corporation Methods for pseudoadenoviral vector production
CA2487328A1 (en) * 1998-03-20 1999-09-30 Benitec Australia Ltd. Sirna for control of gene expression
AUPP249298A0 (en) * 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
US20040214330A1 (en) * 1999-04-07 2004-10-28 Waterhouse Peter Michael Methods and means for obtaining modified phenotypes
US8598332B1 (en) * 1998-04-08 2013-12-03 Bayer Cropscience N.V. Methods and means for obtaining modified phenotypes
US6670188B1 (en) 1998-04-24 2003-12-30 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
EP1435243A3 (de) * 1998-11-13 2005-02-09 Curis, Inc. Verfahren zur Verminderung von Krebssymptomen
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
CA2442144A1 (en) * 2001-03-26 2002-11-21 The Board Of Trustees Of The Leland Stanford Junior University A helper dependent adenoviral vector system and methods for using the same
DE10159167A1 (de) * 2001-12-03 2003-10-02 Guenter Cichon Expressionssystem
DE60329747D1 (de) * 2002-05-02 2009-12-03 Univ Rochester Vektoren mit beiden isoformen von beta-hexosaminidase
US20050101961A1 (en) * 2003-11-12 2005-05-12 Huebner Randall J. Bone screws
JP2006500012A (ja) * 2002-07-31 2006-01-05 ヌクレオニクス インコーポレーティッド 二本鎖ｒｎａの構造および構築物、並びにその作製法および使用法
US20040203133A1 (en) * 2003-01-07 2004-10-14 Anja Ehrhardt Helper dependent adenoviral vector system and methods for using the same
US7686839B2 (en) * 2005-01-26 2010-03-30 Lumitex, Inc. Phototherapy treatment devices for applying area lighting to a wound
ES2337973B8 (es) * 2008-05-16 2011-07-21 Proyecto De Biomedicina Cima, S.L. Adenovirus auxiliares auto-inactivantes para la produccion de adenovirus recombinantes de alta capacidad.
EP2576773A2 (de) * 2010-06-02 2013-04-10 Avir Green Hills Biotechnology Research Development Trade AG Verfahren und helferviren zur erzeugung von rna-viren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3876327D1 (de) * 1987-07-21 1993-01-14 Du Pont Merck Pharma Verfahren fuer die herstellung von in tierischen zellen stabilen und lebensfaehigen rekombinanten viralen vektoren.
US5173414A (en) * 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5919676A (en) * 1993-06-24 1999-07-06 Advec, Inc. Adenoviral vector system comprising Cre-loxP recombination
FR2707664B1 (fr) * 1993-07-13 1995-09-29 Centre Nat Rech Scient Vecteurs viraux et utilisation en thérapie génique.
JP3770333B2 (ja) * 1995-03-15 2006-04-26 大日本住友製薬株式会社 組換えｄｎａウイルスおよびその製造方法

Also Published As

Publication number Publication date
FR2737501B1 (fr) 1997-10-24
AU6704496A (en) 1997-02-26
EP1132478A3 (de) 2002-09-04
WO1997005255A3 (fr) 1997-03-06
EP0842279B1 (de) 2001-10-31
US6066478A (en) 2000-05-23
US20020072120A1 (en) 2002-06-13
JPH11510049A (ja) 1999-09-07
FR2737501A1 (fr) 1997-02-07
AU715487B2 (en) 2000-02-03
EP1132478A2 (de) 2001-09-12
JP3416143B2 (ja) 2003-06-16
EP0842279A2 (de) 1998-05-20
DK0842279T3 (da) 2002-02-25
ATE207959T1 (de) 2001-11-15
CA2225551A1 (fr) 1997-02-13
US6350575B1 (en) 2002-02-26
PT842279E (pt) 2002-04-29
WO1997005255A2 (fr) 1997-02-13
ES2164910T3 (es) 2002-03-01
DE69616559T2 (de) 2002-06-27

Similar Documents

Publication Publication Date Title
ATE207959T1 (de) Hilfsvirus für die herstellung von rekombinanten virusvektoren
ATE358732T1 (de) Anti-virale vektoren
CA2157063A1 (en) Recombinant dna viral vector for transfecting animal cells
NO20014364D0 (no) Ny cytokin-zalphall-ligand
FR2756297B1 (fr) Procede de production de virus recombinants
AU9338598A (en) Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences
EP1006196A3 (de) Retrovirale, mit LCMV-Glykoprotein pseudotypisierte Hybrid-Vektoren
HU904957D0 (en) Parenchymal liver call growth factor, the gene coding this and process for producing transformants creating this factor
KR960001819B1 (en) Viral vector coding for a glycoprotein of the virus responsible
AU3802595A (en) Tripeptidyl aminopeptidase
EP0371119A4 (en) Retroviral vector
NO975813L (no) Innkapslede celler som produserer virale partikler
ATE124454T1 (de) Gentechnische herstellung von faktor xiiia.
AU582288B2 (en) Vector and method for achieving high level expression in eukaryotic cells
CA2263790A1 (en) Method for immortalizing cells
NO881615D0 (no) Fremgangsmaate for fremstilling av proteiner.
DE59109072D1 (de) Klonierung der N-Methylhydantoinase
NO175872C (no) Plasmidvektor, fremgangsmåte for fremstilling av peptider og myelomcelle
KR900009979A (ko) 일본 뇌염 비루스 비구조 단백질의 제조방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee